Resection Should Be Considered Even in Certain Smaller pNETs
Patients who had tumors measuring 1.5 cm to 2 cm were at double the risk for lymph node metastasis.
Pancreatic Cancer
Virtual Molecular Tumor Board May Aid Treatment Selection
As cancer treatments become more complex, tumor boards can help simplify options.
Some Targeted Therapies May Miss the Mark
Ten different drugs continued to kill cancer cells even when their target proteins were removed.
First-in-Class Antibody-Drug Conjugate Advances to Clinical Trial
An antibody-drug conjugate showed antitumor activity in preclinical models for pancreatic cancer, among other cancer types, leading to a phase 1 clinical trial.
Pathologists Need Better Reporting Guidelines for Postneoadjuvant Chemotherapy Specimens
Measuring a tumor’s response to neoadjuvant chemotherapy can be prognostic, providing important clues about a patient’s likely outcome following treatment.
Cognitive Impairment Following Immunotherapy Treatment May Be Underestimated
As more and more patients undergo immunotherapy treatments, understanding possible side effects on cognitive function is an important research gap.
ASTRO Issues Guideline for Radiation Tx in Pancreatic Cancer
Evidence reviewed for radiation therapy in adjuvant, neoadjuvant, definitive, and palliative settings.
Knowing the Appropriateness of Running Noninferiority Trials in Oncology
Researches took a critical look at noninferiority trials and determined that when a new intervention is “not worse,” the possibility exists that it is not better, either.
Experiments in Mice Suggest Fecal Transplantation May Influence Pancreatic Tumor Growth
Researchers showed that survival in pancreatic cancer may be influenced by the tumor microbiome and that tumor growth can be influenced via fecal transplantation.
Dipeptidyl Peptidase-4 Inhibitors May Up Pancreatic Disease Risk
Risks for pancreatitis, pancreatic cancer higher in Korean patients with newly diagnosed T2DM.
Next post in Pancreatic Cancer
